武汉佰乐博生物技术有限公司
   
     
联系热线
  • 联系人:方经理
  • 电 话:027-65279366
  • 邮箱:products@biolabreagent.com
  • 地 址:武汉市东湖新技术开发区神墩四路666号C栋

Anti Digoxin Antibody (26G10)地高辛单克隆抗体

发表时间:2024-06-21

介绍:Digoxin是 Na+/K+-ATPase 的有效抑制剂。该抗体对地高辛(一种从毛地黄植物中提取的心脏糖苷)具有特异性。地高辛用于治疗心房颤动、心房扑动和心力衰竭等心脏疾病,其作用是抑制Na+/K+ atp酶。然而,该药的治疗指标非常狭窄,并可能引起毒副作用。由26-10制备的Fab片段,可以中和地高辛的活性,在洋地黄过量的情况下可以用作解毒剂。抗地高辛单克隆抗体也可以用来测量药物的血清水平,作为治疗的指导,并且在抗体和抗原相互作用动力学的研究中是有用的。

佰乐博生物:佰乐博生物代理AntibodysystemProteoGenix品牌,是亚洲区运营总代理商

链接:https://www.antibodysystem.com/product/8567.html

名称:Anti Digoxin Antibody (26G10)地高辛单克隆抗体

中文名:地高辛;异羟洋地黄毒苷

别名:Digoxin, DGX, CAS: 20830-75-5,digoxinum,12β-hydroxydigitoxin,ChEBI: 4551, 26-10#, 26G10Digoxin Monoclonal Antibody

货号:RGK23001

宿主:Mouse

应用:CLIA, Dot, ELISA, IP, RIA, WB

形式:Liquid

纯度:>95%

克隆:Monoclonal

同型:IgG2a, kappa

内毒素水平Please contact with the lab for this information.

用途范围:仅用于科研

储存:Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

产品购买联系方式:027-65279366 /18162686757

邮箱:biolab-reagents@atagenix.com

QQ:2663991332

 

参考文献:

Digoxin targets low density lipoprotein receptor-related protein 4 and protects against osteoarthritis. PMID: 34853001

Role of Digoxin in Atrial Fibrillation. PMID: 27067743

Digoxin protects against intervertebral disc degeneration via TNF/NF-kappaB and LRP4 signaling. PMID: 37790932

Digoxin--issues and controversies. PMID: 3510096

Digoxin. PMID: 1120872

Digoxin--a redundant drug in congestive cardiac failure. PMID: 2488085

Digoxin toxicity in the aged. Characterising and avoiding the problem. PMID: 1794026

Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia. PMID: 35064518

[Digoxin]. PMID: 3185769

[A baby with digoxin toxicity]. PMID: 25944069

A nomogram for digoxin therapy. PMID: 4600984

Clinical pharmacokinetics of digoxin 1980. PMID: 6988136

Digoxin therapy: textbooks, theory and practice. PMID: 22216507

Digoxin bioavailability. PMID: 82124

A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile. PMID: 24574198

Digoxin in the 1980s. PMID: 3309595

Computer-assisted digoxin therapy. PMID: 4763409

Quinidine-digoxin interaction. PMID: 7436201

Clinical pharmacology of digoxin. PMID: 4558886

How to digitalize and to maintain optimal digoxin levels in congestive heart failure. PMID: 2488083

Digoxin: placental transfer, effects on the fetus, and therapeutic use in the newborn. PMID: 1102216

Digoxin in heart failure. PMID: 2569093

Serum digoxin concentrations in atrial fibrillation: a review. PMID: 7049644

Digoxin therapeutics: straightening out the facts. PMID: 1513197

The rational pharmacology of digoxin. PMID: 1389200

Population Pharmacokinetic Studies of Digoxin in Adult Patients: A Systematic Review. PMID: 33616855

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. PMID: 26112191

Understanding digoxin use in the elderly patient. PMID: 2253445

Pharmacokinetics of digoxin in the rat. PMID: 3407

Is there an expanded role for digoxin in patients with heart failure and sinus rhythm? A protagonist viewpoint. PMID: 9220052

Digoxin metabolism in patients. PMID: 666466

Serum digoxin test in perspective. PMID: 912635

Bioavailability of digoxin. PMID: 4113330

联系方式
手机:18162686757
微信扫一扫